Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 13/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 2/20 | 0.37 |
| ▸ | KDR | P35968 | 2/20 | 0.37 |
| ▸ | JAK3 | P52333 | 2/20 | 0.37 |
| ▸ | TNK2 | Q07912 | 2/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | UBE2N | P61088 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13985760 | 0.89 | AURKA (0.41) | AURKACHEK1AURKBLCKKDR | |
| SCHEMBL3053586 | 0.86 | AURKA (0.42) | AURKACHEK1AURKBLCKKDR | |
| SCHEMBL13985691 | 0.81 | CHEK1 (0.40) | AURKACHEK1AURKBEGFR | |
| SCHEMBL3051118 | 0.80 | CHEK1 (0.41) | AURKACHEK1AURKBLCKKDR | |
| SCHEMBL3047782 | 0.78 | LCK (0.43) | AURKACHEK1AURKBLCKKDR | |
| SCHEMBL13087632 | 0.76 | AURKA (0.40) | AURKACHEK1AURKBLCKKDR | |
| SCHEMBL3042868 | 0.76 | LCK (0.50) | AURKACHEK1AURKBLCKKDR | |
| SCHEMBL3052580 | 0.76 | AURKA (0.40) | AURKACHEK1AURKBEGFRKDM4E | |
| SCHEMBL3056028 | 0.75 | CHEK1 (0.44) | AURKACHEK1LCKKDRJAK3 | |
| SCHEMBL3053707 | 0.75 | AURKA (0.47) | AURKACHEK1LCKKDRJAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008155017-A1 | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-12-24 | — | — | WO | disclosed |